Moderna, Inc. (MRNA) SEC Filings — 2024
16 SEC filings for Moderna, Inc. (MRNA) in 2024.
Filings
- Moderna Files Q3 2024 10-Q with Financial Updates — 10-Q · Nov 7, 2024
- Moderna 8-K: Executive Changes & Financials — 8-K · Oct 2, 2024
- Moderna Files 8-K: Financials & Reg FD Update — 8-K · Sep 12, 2024
- Moderna Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Moderna 8-K: Board Changes and Executive Compensation — 8-K · Jul 23, 2024
- Moderna Files 8-K: Shareholder Vote & Financials — 8-K · May 9, 2024
- Moderna, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Moderna, Inc. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- Moderna, Inc. DEF 14A Filing — DEF 14A · Mar 21, 2024
- Moderna, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 23, 2024
- Moderna Files 8-K on Financial Condition and Operations — 8-K · Feb 22, 2024
- Moderna, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Moderna CEO Bancel Holds 30.38M Shares, Signals Confidence — SC 13G/A · Feb 7, 2024
- Baillie Gifford Amends Moderna Stake, Signals Ownership Change — SC 13G/A · Jan 29, 2024
- BlackRock Updates Passive Stake in Moderna (MRNA) via SC 13G/A — SC 13G/A · Jan 29, 2024
- Moderna 8-K Signals Upcoming Financial Disclosure — 8-K · Jan 8, 2024